Skip to content

Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore

This deal also marks the entry of Eris into the RoW Export Markets.

Read More

​ This deal also marks the entry of Eris into the RoW Export Markets. This deal also marks the entry of Eris into the RoW Export Markets.  Moneycontrol Latest News Read More  

Leave a Reply

en_USEnglish